8-KOther EventsExhibits & Filings

CARDINAL HEALTH INC 8-K Report, Corporate Update (Jun 5, 2017)

Filed June 5, 2017For Securities:CAH

Summary

This 8-K filing by Cardinal Health Inc. (CAH) on June 5, 2017, primarily announces two significant debt-related actions. The company entered into an underwriting agreement to issue approximately $5.75 billion in aggregate principal amount of new notes across various maturities and interest rates. This move suggests Cardinal Health is strategically managing its capital structure, potentially to refinance existing debt, fund growth initiatives, or for general corporate purposes. The issuance is being made under a previously filed Form S-3 registration statement. Concurrently, Cardinal Health also issued a notice for the full redemption of its outstanding 1.700% Notes due 2018, which will be redeemed on July 1, 2017, at a "make-whole" price. This redemption indicates a proactive approach to optimizing its debt obligations, likely replacing higher-cost or maturing debt with new issuances at favorable rates, as evidenced by the various coupon rates on the newly issued notes. Investors should view these actions as management's efforts to enhance financial flexibility and potentially reduce interest expenses.

Key Highlights

  • 1Cardinal Health issued $5.75 billion in new notes with various maturities and interest rates on June 1, 2017.
  • 2The new notes include denominations ranging from 1.948% to 4.368% across different due dates.
  • 3The debt issuance was conducted under an effective Form S-3 registration statement filed previously.
  • 4The company concurrently announced the full redemption of its 1.700% Notes due 2018.
  • 5The redemption of the 2018 notes is scheduled for July 1, 2017, at a 'make-whole' price.
  • 6The filing details the underwriting agreement with several prominent financial institutions.
  • 7These actions suggest a strategic refinancing and management of the company's debt profile.

Frequently Asked Questions

Cardinal Health is issuing an aggregate principal amount of $5,750,000,000 in new notes. This includes $1,000,000,000 of 1.948% Notes due 2019, $1,150,000,000 of 2.616% Notes due 2022, $350,000,000 of Floating Rate Notes due 2022, $750,000,000 of 3.079% Notes due 2024, $1,350,000,000 of 3.410% Notes due 2027, and $600,000,000 of 4.368% Notes due 2047.

Companies often issue new debt and redeem old debt to optimize their capital structure, potentially lowering their overall cost of borrowing, extending maturity dates, or aligning debt with strategic business needs. In this case, Cardinal Health may be replacing maturing or higher-interest debt with these new issuances, which have varied rates and maturities, indicating a proactive debt management strategy.

A 'make-whole' redemption price is typically higher than the face value of the bonds. It compensates bondholders for the anticipated loss of future interest payments due to early redemption. The exact calculation is based on the terms outlined in the indenture for those specific notes.

For investors, this large debt issuance signals that Cardinal Health is actively managing its balance sheet. The variety of interest rates and maturities on the new notes suggests a strategy to secure funding at potentially favorable terms. The redemption of existing notes also indicates a focus on financial efficiency. Investors should consider how these new debt obligations impact the company's leverage ratios and interest expense coverage.